ZypAdhera ® (olanzapine pamoate monohydrate)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).

ZypAdhera® (olanzapine pamoate): Use in Patients Following a Vegetarian or Vegan Diet

ZypAdhera (including the solvent) does not contain ingredients sourced from animals or animal products including blood, dairy and eggs.

Label Information

The active ingredient of ZypAdhera is olanzapine pamoate.1

The excipients of ZypAdhera are:1


  • None


  • Carmellose sodium

  • Mannitol

  • Polysorbate 80

  • Water for injections

  • Hydrochloric acid (for pH adjustment)

  • Sodium hydroxide (for pH adjustment)


1. ZypAdhera [summary of product characteristics] Eli Lilly Netherland B.V., The Netherlands.

Date of Last Review: 13 February 2020

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request